Back toCRVS
CRVS

Corvus Pharmaceuticals, Inc. (CRVS) earnings date, market-implied expected move, and options open interest by expiry

earnings room

12.56+0.04%

Next report

fiscal Q3 2026
Nov 5

after close · estimated date

47

days out

Track CRVS

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.

Not investment advice. Varamir is not a brokerage and does not execute orders. Prices via Intrinio; the tape shows ETF proxies. The supply-chain graph is published under CC BY 4.0; licensed market data is not redistributable.